ERBB4 is a receptor tyrosine kinase that mediates neuregulin and EGF family signaling with critical roles across multiple physiological systems. As a cell-surface receptor for neuregulins (NRG1-4) and EGF family members, ERBB4 undergoes ligand-induced dimerization and autophosphorylation to activate downstream signaling cascades 1. The receptor regulates diverse cellular processes including proliferation, differentiation, migration, and apoptosis through activation of MAPK/ERK and PI3K/AKT pathways 2. Developmentally, ERBB4 is essential for cardiac muscle differentiation and postnatal cardiomyocyte proliferation; erbB4 null mice die by embryonic day 11 due to defective cardiac trabeculation 1. The receptor also directs central nervous system development, neural crest migration, and mammary gland differentiation with proteolytic cleavage generating soluble intracellular domains that translocate to the nucleus and mitochondria 3. Alternative splicing generates functionally distinct isoforms with differential abilities to activate pro-survival and migration pathways. Clinically, ERBB4 dysfunction associates with amyotrophic lateral sclerosis and neurological disorders including schizophrenia and Alzheimer's disease 2. In cancer, ERBB4 exhibits paradoxical roles: homodimers function as tumor suppressors while heterodimers with EGFR or ERBB2 act as oncogenes 4. ERBB4 selectively amplifies TGF-β-induced metastatic responses through SMAD4 phosphorylation 5. Small-molecule ERBB4 activators show promise for heart failure treatment 6.